229 related articles for article (PubMed ID: 16527611)
1. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
Hsiao HH; Sashida G; Ito Y; Kodama A; Fukutake K; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
[TBL] [Abstract][Full Text] [Related]
2. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
[TBL] [Abstract][Full Text] [Related]
3. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
4. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
[TBL] [Abstract][Full Text] [Related]
5. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
6. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
[TBL] [Abstract][Full Text] [Related]
7. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
8. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
10. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
12. [Chromosomal structural changes in patients with myelodysplastic syndrome].
Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
[TBL] [Abstract][Full Text] [Related]
13. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
Lin P; Medeiros LJ; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
[TBL] [Abstract][Full Text] [Related]
14. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.
Aktas D; Tuncbilek E
Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595
[TBL] [Abstract][Full Text] [Related]
16. Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities.
Estey EH; Pierce S; Keating MJ
Haematologica; 2000 Mar; 85(3):246-9. PubMed ID: 10702811
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements.
Lindvall C; Nordenskjöld M; Porwit A; Björkholm M; Blennow E
Haematologica; 2001 Nov; 86(11):1158-64. PubMed ID: 11694401
[TBL] [Abstract][Full Text] [Related]
18. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic characteristics and prognosis analysis in 231 myelodysplastic syndrome patients from a single institution.
Jung SW; Lee SY; Jekarl DW; Kim M; Lim J; Kim Y; Han K; Kim YJ; Cho SG; Song J
Leuk Res; 2011 Jun; 35(6):735-40. PubMed ID: 21146871
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]